Kenzo Ohara

772 total citations
36 papers, 553 citations indexed

About

Kenzo Ohara is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Kenzo Ohara has authored 36 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Oncology and 7 papers in Surgery. Recurrent topics in Kenzo Ohara's work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (11 papers) and interferon and immune responses (5 papers). Kenzo Ohara is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (11 papers) and interferon and immune responses (5 papers). Kenzo Ohara collaborates with scholars based in Japan, United States and Switzerland. Kenzo Ohara's co-authors include Toshihiro Nagato, Takayuki Ohkuri, Yasuaki Harabuchi, Akemi Kosaka, Takumi Kumai, Hiroya Kobayashi, Kensuke Oikawa, Naoko Aoki, Kei Ishibashi and Esteban Celis and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Kenzo Ohara

31 papers receiving 550 citations

Peers

Kenzo Ohara

IMMUN

ONCOL

PFM

Miao-La Ke China

Yui Hirata Japan

Uxua Mancheño Spain

Elizabeth M. Sagatys United States

Yongxiang Yan China

Esperanza Feijoó Spain

Martín Bonamino Brazil

James M. Coghill United States

Mackenzie L. Shindorf United States

Fumihiro Fujiki Japan

Miao-La Ke China

Kenzo Ohara

249 ×0.6

IMMUN

266 ×1.0

ONCOL

145 ×0.9

100 ×1.2

PFM

38 ×0.6

Citations per year, relative to Kenzo Ohara Kenzo Ohara (= 1×) peers Miao-La Ke

Countries citing papers authored by Kenzo Ohara

Since Specialization

Citations

This map shows the geographic impact of Kenzo Ohara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenzo Ohara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenzo Ohara more than expected).

Fields of papers citing papers by Kenzo Ohara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenzo Ohara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenzo Ohara. The network helps show where Kenzo Ohara may publish in the future.

Co-authorship network of co-authors of Kenzo Ohara

This figure shows the co-authorship network connecting the top 25 collaborators of Kenzo Ohara. A scholar is included among the top collaborators of Kenzo Ohara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenzo Ohara. Kenzo Ohara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inoue, Takahiro, Kenzo Ohara, Akemi Kosaka, et al.. (2025). Differences in PD‐L1, PD‐L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study. Head & Neck. 47(8). 2260–2269. 1 indexed citations

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2024). Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer. Head & Neck. 46(8). 2056–2067. 2 indexed citations

Ohara, Kenzo, et al.. (2024). Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD‐L1 and PD‐L2. Head & Neck. 46(9). 2233–2243. 2 indexed citations

Ohara, Kenzo, et al.. (2024). Comparative outcomes of video-assisted thyroidectomy and traditional open surgery: a 5-year analysis of a single center experience. Brazilian Journal of Otorhinolaryngology. 91(2). 101539–101539.

Nagato, Toshihiro, Miki Takahara, Takayuki Ohkuri, et al.. (2024). Soluble CD27 as a predictive biomarker for intra‐tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. Cancer Science. 115(4). 1073–1084. 4 indexed citations

Kumai, Takumi, Kenzo Ohara, Kan Kishibe, et al.. (2024). Prognostic Value of the ¹⁸ F ‐ FDG PET / CT and Haematological Parameters in Head and Neck Cancer. Clinical Otolaryngology. 49(6). 733–741. 1 indexed citations

Ohara, Kenzo, Takumi Kumai, Kan Kishibe, et al.. (2024). A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study. Clinical and Experimental Nephrology. 28(12). 1254–1260.

Nagato, Toshihiro, Takayuki Ohkuri, Kenzo Ohara, et al.. (2023). Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer. Cancer Immunology Immunotherapy. 72(8). 2799–2812. 5 indexed citations

Takahara, Miki, et al.. (2023). Treatment outcomes of sialendoscopy for submandibular gland sialolithiasis. Auris Nasus Larynx. 50(5). 783–789. 1 indexed citations

10.

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2022). Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation. Cancer Science. 114(2). 399–409. 4 indexed citations

11.

Ohara, Kenzo, Akihiro Katada, Takumi Kumai, et al.. (2022). Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases. Auris Nasus Larynx. 50(4). 628–631.

12.

Ohara, Kenzo, Miki Takahara, Takumi Kumai, et al.. (2022). Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study. Brazilian Journal of Otorhinolaryngology. 89(3). 440–446. 2 indexed citations

13.

Kosaka, Akemi, Kei Ishibashi, Shunsuke Yasuda, et al.. (2022). A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. Cancer Science. 113(8). 2526–2535. 8 indexed citations

14.

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2022). Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. OncoImmunology. 11(1). 2021619–2021619. 23 indexed citations

15.

Kosaka, Akemi, Kei Ishibashi, Toshihiro Nagato, et al.. (2021). CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. The Journal of Experimental Medicine. 218(11). 44 indexed citations

16.

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2021). Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery. Cancer Immunology Immunotherapy. 70(12). 3421–3434. 11 indexed citations

17.

Kosaka, Akemi, Kenzo Ohara, Hiroshi Funakoshi, et al.. (2021). A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment. Cancer Immunology Immunotherapy. 70(8). 2301–2312. 20 indexed citations

18.

Ohara, Kenzo, Takumi Kumai, Takayuki Ohkuri, et al.. (2020). Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer. Cancer Immunology Immunotherapy. 69(6). 989–999. 19 indexed citations

19.

Kosaka, Akemi, Takumi Kumai, Kenzo Ohara, et al.. (2019). Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma. Biochemical and Biophysical Research Communications. 522(2). 408–414. 19 indexed citations

20.

Ishibashi, Kei, Takumi Kumai, Takayuki Ohkuri, et al.. (2016). Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy. OncoImmunology. 5(6). e1169356–e1169356. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact